Study of the Acceptability and Psychosocial Impact of Using a Telepresence Robot in the Living Space of Inpatients
NCT ID: NCT04899830
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2020-10-24
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment
NCT05528302
Investigation of the Use of Remote Presence Robots in Delivery of Neuromodulation
NCT01283633
Feasibility and Acceptability of a Web-based Multidomain Intervention to Maintain Cognitive Function in Older Adults
NCT03336320
Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving
NCT04259151
Cognitive Inhibition, Psychosocial Interactions and Suicide Attempt in Elderly
NCT02858427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Installation of a telepresence robot in the home of a disabled person hospitalized in a PRM center
From the application installed on a tablet, the patient hospitalized in a center for a period of at least 2 months can start from the center where he is hospitalized the mobile robotic telepresence assistance device installed at home to communicate with his family, his friends, his neighbors,…)
Telepresence robot
From the application installed on a tablet, the patient hospitalized in a center for a period of at least 2 months can start from the center where he is hospitalized the mobile robotic telepresence assistance device installed at home to communicate with his family, his friends, his neighbors,…)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telepresence robot
From the application installed on a tablet, the patient hospitalized in a center for a period of at least 2 months can start from the center where he is hospitalized the mobile robotic telepresence assistance device installed at home to communicate with his family, his friends, his neighbors,…)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliation to a social security scheme or beneficiary of such a scheme
* Having signed a free informed consent in writing
* Hospitalized in PRM for a foreseeable period of at least 60 days
* Living space compatible with the movement of the robot (verified by a home visit by the center's occupational therapist) and equipped with wifi
* Cognitive and motor functions compatible with the use of the tablet or phone independently, with learning capabilities to use the robot and the completion of questionnaires and interviews remotely
* Medically stable
Exclusion Criteria
* Mood and behavior disorders not stabilized
* Insufficient command of the French language
* Protected adults (guardianship / curatorship)
* Pregnant or breastfeeding women
* Persons deprived of their liberty
* Being unable to issue their consent
* Person who has already presented a form of addiction to technologies and / or video games
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LP3C, University of Rennes 2
UNKNOWN
COVEA
UNKNOWN
Association APPROCHE
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thibaud Honoré, Doctor
Role: PRINCIPAL_INVESTIGATOR
CMRRF de Kerpape
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CR Mulhouse
Mulhouse, Alsace, France
IUR Clémenceau
Strasbourg, Alsace, France
CMRRF de Kerpape
Ploemeur, Brittany Region, France
CMPR Côte d'Amour
Saint-Nazaire, Pays de la Loire Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A02088-49
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.